Student or educator? Sign up with your school email and get 6 months of Pro free.

The DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.

U1 snRNP regulates cancer cell migration and invasion in vitro

Open access

Published version of a preprint

Abstract

Stimulated cells and cancer cells have widespread shortening of mRNA 3’-untranslated regions (3’UTRs) and switches to shorter mRNA isoforms due to usage of more proximal polyadenylation signals (PASs) in introns and last exons. U1 snRNP (U1), vertebrates’ most abundant non-coding (spliceosomal) small nuclear RNA, silences proximal PASs and its inhibition with antisense morpholino oligonucleotides (U1 AMO) triggers widespread premature transcription termination and mRNA shortening. Here we show that low U1 AMO doses increase cancer cells’ migration and invasion in vitro by up to 500%, whereas U1 over-expression has the opposite effect. In addition to 3’UTR length, numerous transcriptome changes that could contribute to this phenotype are observed, including alternative splicing, and mRNA expression levels of proto-oncogenes and tumor suppressors. These findings reveal an unexpected role for U1 homeostasis (available U1 relative to transcription) in oncogenic and activated cell states, and suggest U1 as a potential target for their modulation.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41467-019-13993-7

Cites

58 of 58 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Low U1 AMO dose-dependently enhances migration and invasion of HeLa cells in vitro. a HeLa cells were transfected with the indicated amounts of U1 or control AMOs. Cell proliferation was determined from cell numbers using the Cell Titer-Glo Luminescent Cell Viability Assay at the times indicated. Data are represented as mean ± standard deviation (SD) (n = 3, independent cell culture). P-value was calculated with two-tailed Student’s t-test. The asterisk indicates P < 0.05. b, c Migrating and invading cells were measured 24 h post-transfection. 1.5 × 105 and 2.5 × 105 cells were cultured for the migration and invasion assays, respectively. Cells migrated and invaded from an upper chamber to a bottom chamber over 24 h and were counted using the cell staining solution Cytoselect 24-well cell migration assay kit (Cell Biolabs). The number of migrated and invaded cells were compared with each control. Data are represented as mean ± SD (n = 3, independent cell culture). P-value was calculated with two-tailed Student’s t-test. d, e Migrating and invading cells were stained 24 h after transfection and visualized by phase-contrast microscopy (10x magnification). The number of migrated cells were 111, 344, 472, and 26 in control, 2.5, 62.5, and 250 U1 AMO (pmole), respectively. The number of invaded cells were 124, 472, 532, and 88 in control, 2.5, 62.5, and 250 U1 AMO (pmole), respectively. Scale bar = 250 µm. Source data are provided as a Source Data file.
Fig. 1 Low U1 AMO dose-dependently enhances migration and invasion of HeLa cells in vitro. a HeLa cells were transfected with the indicated amounts of U1 or control AMOs. Cell proliferation was determined from cell numbers using the Cell Titer-Glo Luminescent Cell Viability Assay at the times indicated. Data are represented as mean ± standard deviation (SD) (n = 3, independent cell culture). P-value was calculated with two-tailed Student’s t-test. The asterisk indicates P < 0.05. b, c Migrating and invading cells were measured 24 h post-transfection. 1.5 × 105 and 2.5 × 105 cells were cultured for the migration and invasion assays, respectively. Cells migrated and invaded from an upper chamber to a bottom chamber over 24 h and were counted using the cell staining solution Cytoselect 24-well cell migration assay kit (Cell Biolabs). The number of migrated and invaded cells were compared with each control. Data are represented as mean ± SD (n = 3, independent cell culture). P-value was calculated with two-tailed Student’s t-test. d, e Migrating and invading cells were stained 24 h after transfection and visualized by phase-contrast microscopy (10x magnification). The number of migrated cells were 111, 344, 472, and 26 in control, 2.5, 62.5, and 250 U1 AMO (pmole), respectively. The number of invaded cells were 124, 472, 532, and 88 in control, 2.5, 62.5, and 250 U1 AMO (pmole), respectively. Scale bar = 250 µm. Source data are provided as a Source Data file.CC BY · PubMed Central
Fig. 2 U1 over-expression decreases cell migration and invasion of HeLa cells in vitro. HeLa cells were transfected with control empty vector or U1 expression plasmids. a Cell growth determined in 24 h intervals. The data are represented as mean ± SD (n = 3, independent cell culture). b, c Cell migration and invasion were measured 24 h after transfection. The bars indicate mean ± SD (n = 3, independent cell culture). P-value was calculated with two-tailed Student’s t-test. d, e Cell migration and invasion were determined 24 h post-transfection and imaged by phase-contrast microscopy (10x magnification). Scale bar = 250 µm. Source data are provided as a Source Data file.
Fig. 2 U1 over-expression decreases cell migration and invasion of HeLa cells in vitro. HeLa cells were transfected with control empty vector or U1 expression plasmids. a Cell growth determined in 24 h intervals. The data are represented as mean ± SD (n = 3, independent cell culture). b, c Cell migration and invasion were measured 24 h after transfection. The bars indicate mean ± SD (n = 3, independent cell culture). P-value was calculated with two-tailed Student’s t-test. d, e Cell migration and invasion were determined 24 h post-transfection and imaged by phase-contrast microscopy (10x magnification). Scale bar = 250 µm. Source data are provided as a Source Data file.CC BY · PubMed Central
Fig. 3 Examples of genes with 3’UTR shortening by U1 AMO and genes with 3’UTR lengthening from U1 over-expression. Venn diagrams of LECDS-identified genes affected by 3ʹUTR shortening versus 3ʹUTR lengthening in U1 AMO 12.5 and 62.5 pmole (a) and U1 OE 1 and 1.5 µg (b) samples. c Cells transfected with control or U1 AMO (12.5 and 62.5 pmole, 8 h) were labeled with 4-thiouridine to select and sequence nascent transcripts. RNA-seq maps of representative genes from two biological experiments are shown. Green dotted boxes indicate the affected regions where shortening in the 3ʹUTR occurs. d Cells transfected with control or U1 expression plasmids (1 µg and 1.5 µg, 24 h) were labeled with 4-thiouridine to select nascent transcripts. Green dotted boxes indicate the regions where there was a switch towards longer 3ʹUTRs. miRNA target sites that are involved in cancer and expressed in HeLa are shown.
Fig. 3 Examples of genes with 3’UTR shortening by U1 AMO and genes with 3’UTR lengthening from U1 over-expression. Venn diagrams of LECDS-identified genes affected by 3ʹUTR shortening versus 3ʹUTR lengthening in U1 AMO 12.5 and 62.5 pmole (a) and U1 OE 1 and 1.5 µg (b) samples. c Cells transfected with control or U1 AMO (12.5 and 62.5 pmole, 8 h) were labeled with 4-thiouridine to select and sequence nascent transcripts. RNA-seq maps of representative genes from two biological experiments are shown. Green dotted boxes indicate the affected regions where shortening in the 3ʹUTR occurs. d Cells transfected with control or U1 expression plasmids (1 µg and 1.5 µg, 24 h) were labeled with 4-thiouridine to select nascent transcripts. Green dotted boxes indicate the regions where there was a switch towards longer 3ʹUTRs. miRNA target sites that are involved in cancer and expressed in HeLa are shown.CC BY · PubMed Central
Fig. 4 Low U1 AMO causes widespread alternative splicing changes in HeLa cells. a Summary of alternative splicing events as identified with JUM analysis. Each alternative splicing event happened in both low U1 AMO 12.5 and 62.5 pmole in HeLa cells. (A5’SS: alternative 5ʹ splice site; A3’SS: alternative 3ʹ splice site; CE: cassette exon; IR: intron retention; MXE: mutually exclusive exons) b Sashimi plots and genome browser view of each alternative splicing change in the low U1 AMO 12.5 and 62.5 pmole.
Fig. 4 Low U1 AMO causes widespread alternative splicing changes in HeLa cells. a Summary of alternative splicing events as identified with JUM analysis. Each alternative splicing event happened in both low U1 AMO 12.5 and 62.5 pmole in HeLa cells. (A5’SS: alternative 5ʹ splice site; A3’SS: alternative 3ʹ splice site; CE: cassette exon; IR: intron retention; MXE: mutually exclusive exons) b Sashimi plots and genome browser view of each alternative splicing change in the low U1 AMO 12.5 and 62.5 pmole.CC BY · PubMed Central
Fig. 5 U1 AMO upregulated oncogenes and downregulates tumor suppressor genes and U1 over-expression antagonizes the effect in HeLa cells. Heat map showing genes related to cell cycle and tumor suppressor function are downregulated in U1 AMO and upregulated in U1 OE. Oncogene and cancer related genes are upregulated in U1 AMO and downregulated in U1 OE (1.5-fold change, P-value < 0.01 calculated by GFold55). Source data are provided as a Source Data file.
Fig. 5 U1 AMO upregulated oncogenes and downregulates tumor suppressor genes and U1 over-expression antagonizes the effect in HeLa cells. Heat map showing genes related to cell cycle and tumor suppressor function are downregulated in U1 AMO and upregulated in U1 OE. Oncogene and cancer related genes are upregulated in U1 AMO and downregulated in U1 OE (1.5-fold change, P-value < 0.01 calculated by GFold55). Source data are provided as a Source Data file.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

7 more claims about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 58 references

Cited by

See all 7,157

Metadata

Authors
Oh, J.-M., Venters, C. C., Di, C., Pinto, A. M., Wan, L., Younis, I., Cai, Z., Arai, C., So, B. R., Duan, J., & Dreyfuss, G.
Affiliations
Howard Hughes Medical Institute (US)
Corresponding author
Dreyfuss, Gideon
Venue
Nature Communications
Published
2020-01-07
Volume
11
Issue
1
Pages
1-1
ISSN
2041-1723 (ISSN-L)
OpenAlex
W2998840182
Cited by
7,157
References
58
Citations by year
2026: 81 · 2025: 706 · 2024: 808 · 2023: 1381 · 2022: 1956 · 2021: 1753 · 2020: 471
FWCI
451.98
Type
journal article
Language
en
Open access
Licence
Locations
  • Nature Communications (publishedVersion, cc-by)
  • bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • RePEc: Research Papers in Economics (submittedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
  • Use Siena air (University of Siena) (submittedVersion, cc-by)
Funders
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (R01GM112923)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Research and Splicing
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer-related molecular mechanisms research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA regulation and disease
Keywords
U1 snRNP, tumor cell migration, tumor invasion, polyadenylation signal, premature transcription termination, morpholino antisense oligonucleotides, alternative splicing, proto-oncogenes, tumor suppressor, transcriptome changes
MeSH terms
Cell Movement, Humans, Neoplasm Invasiveness, Neoplasms, RNA Splicing, RNA, Messenger, Oligonucleotides, Antisense, Ribonucleoprotein, U1 Small Nuclear, Cell Line, Tumor

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: U1 snRNP regulates cancer cell migration and invasion in vitro. https://app.cochat.ai/papers/10.1038/s41467-019-13993-7
The paper
Oh, J.-M., Venters, C. C., Di, C., Pinto, A. M., Wan, L., Younis, I., Cai, Z., Arai, C., So, B. R., Duan, J., & Dreyfuss, G. (2020). U1 snRNP regulates cancer cell migration and invasion in vitro. Nature Communications. https://doi.org/10.1038/s41467-019-13993-7

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.